Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Establishment Labs Holdings Inc. (ESTA)

72.30 -2.62 (-3.50%)
At close: September 3 at 4:00:01 PM EDT
72.30 0.00 (0.00%)
Pre-Market: 8:18:04 AM EDT
Trade ESTA on Coinbase
Chart Range Bar
Loading chart for ESTA
  • Previous Close 74.92
  • Open 75.24
  • Bid 54.36 x 200
  • Ask 97.52 x 200
  • Day's Range 72.23 - 76.42
  • 52 Week Range 36.53 - 97.59
  • Volume 352,063
  • Avg. Volume 598,460
  • Market Cap (intraday) 2.155B
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -1.27
  • Earnings Date (est.) Nov 4, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 102.44

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

www.establishmentlabs.com

1,004

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ESTA
0.80%
S&P 500 (^GSPC)
13.18%

1-Year Return

ESTA
88.43%
S&P 500 (^GSPC)
20.15%

3-Year Return

ESTA
21.51%
S&P 500 (^GSPC)
71.57%

5-Year Return

ESTA
3.19%
S&P 500 (^GSPC)
70.83%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 67.54M
Earnings -11.75M
Profit Margin -17.39%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20M
40M
60M
-20.0%
-15.0%
-10.0%
-5.0%

Analyst Insights

View More

Analyst Price Targets

92.00
102.44 Average
72.30 Current
117.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/1/2026
Analyst BTIG
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 103 -> 103

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    2.08B

  • Enterprise Value

    2.27B

  • Trailing P/E

    --

  • Forward P/E

    212.77

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.56

  • Price/Book (mrq)

    96.05

  • Enterprise Value/Revenue

    9.23

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.82%

  • Return on Assets (ttm)

    -3.44%

  • Return on Equity (ttm)

    -175.30%

  • Revenue (ttm)

    245.82M

  • Net Income Avi to Common (ttm)

    -38.89M

  • Diluted EPS (ttm)

    -1.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    71.16M

  • Total Debt/Equity (mrq)

    1,220.32%

  • Levered Free Cash Flow (ttm)

    -19.29M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

72.30 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: